Financials • Life Insurance
$100.83 ▲ +1.19
(+1.19%)
MKT CAP: $64.08B • VOL: 2.96M
52W L $67 52W H $104
MET // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.44B | $2.25B | $2.23B |
| YoY Revenue Growth % | +8.5% | +0.7% | — |
| Gross Profit | $1.07B | $987.8M | $980.8M |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $6.14B | $6.00B | $5.72B |
| Operating Margin % | 251.9% | 267.1% | 256.8% |
| Net Income (GAAP) | $3.17B | $4.23B | $1.38B |
| EBITDA (Normalized) | $6.22B | $6.08B | $5.80B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $17.09B | $14.60B | $13.72B |
| Capital Expenditures (CapEx) | $109.6M | $101.0M | $100.3M |
| Free Cash Flow (FCF) | $16.98B | $14.50B | $13.62B |
| FCF Margin % | 697.1% | 645.7% | 611.1% |
| Return on Invested Capital (ROIC %) | 1.5% | 1.6% | 21.2% |
| Cash & Short-Term Equivalents | $22.03B | $20.07B | $3.88B |
| Total Debt (Short + Long Term) | $322.31B | $292.39B | $8.25B |
| Total Stockholders' Equity | $28.40B | $27.45B | $16.92B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MET.